川崎市殿町にあるライフサイエンス系インキュベーターiCONM in collaboration with BioLabsでは、2/22（木）9amより、BioLabsと共同でウェビナーを開催いたします。「Crafting a winning pitch」をテーマとし、特にバイオ系スタートアップのグローバルでのピッチの仕方について、レクチャーを行います。ピッチという短い時間で聞き手は何を求めているか？相手のフォーカスポイントに合わせて、自社をアピールするコツを掴みましょう。よろしければ、ぜひご聴講ください。
※3月にはグローバルピッチイベント”Global life-science pitch 2024“を実施します。現在、聴講者を募集しておりますので、よろしければご参加ください。
Life Science Entrepreneur Webinar Series: Crafting a winning pitch
Pitching your business venture is a skill all entrepreneurs need to embrace and master. This is especially critical for life-science start-ups. As you navigate this fundraising journey, how will you sell your science and capture investors’ attention?
Join iCONM in collaboration with BioLabs for another installment of the Life Science Entrepreneur Webinar Series and learn tips for creating a winning biotech pitch deck from investors.
2024年2月22日（木） 9:00 – 10:00AM
Cassidy Blundell, PhD is a Principal based in Mission BioCapital’s Cambridge office. She is responsible for sourcing and assessing new investment opportunities as part of the diligence team as well as assisting in management of the portfolio. She holds board roles at ARase Therapeutics, Mediar Therapeutics, and Volnay Therapeutics. Before joining Mission BioCapital as an analyst in 2018, Cassidy completed her graduate studies at the University of Pennsylvania in the HHMI Interfaces program. Cassidy’s doctoral research focused on development of microengineered in vitro systems to study the human placenta which were used to investigate maternal-fetal transport and placental development. Cassidy holds a PhD in Bioengineering from the University of Pennsylvania and a B.S. in Biomedical Engineering from Boston University.
Kristina Kitko, PhD is currently Associate Director of Venture Science at Eli Lilly. She is based in San Francisco CA as part of the broader West Coast group within Global Corporate Business Development primarily targeting early-stage research across Lilly’s 5 core therapeutic areas. Her role supports Lilly’s multiple external venture investments in both funds and companies globally (>$2B) as well as due diligence and search and evaluation initiatives. She works on deals across multiple modalities and therapeutic areas for Lilly.Kristina comes from an operational background within biotech. Prior to Lilly she worked in Corporate Strategy at Crinetics Pharmaceuticals and in venture creation at Flagship Pioneering and as an independent consultant. Kristina completed her PhD in Interdisciplinary Materials Science from Vanderbilt University as an NSF IGERT fellow and her postdoctoral training in Brain and Cognitive Sciences at MIT.
Head of Global Discovery Business Development,
Evotec International GmbH
Ryan Brady is a seasoned pharma and biotech Business Development Executive, with over 20 years of drug development and strategic transactions expertise. Ryan began his career as an organic chemist at Eli Lilly and Co. in Indianapolis. From the beginning he has been passionate about facilitating innovation in creative ways. This led Ryan to transition from the lab to Lilly’s External Innovations group, where he supported strategic relationships and helped move external innovations forward. Following Lilly, Ryan joined BioDuro in Beijing, China where he built and led a global BD team focused on the U.S., Europe, and Japan. Since 2012, Ryan has been a leader in Evotec’s business development team where he has been instrumental in growing and shaping Evotec’s global business development strategy Discovery R&D group. Ryan is responsible for developing, leading, and executing creative deals including working with many early-stage biotech’s and creation of NewCo’s leveraging Evotec’s assets and platforms that have helped Evotec become and continue to be a strategic research and development partner to many life sciences companies.
Lindsay Bourgeois joins us with several years of experience developing startups as both Site Manager and Director of Operations for Lake Pharma, and Director of Program Management at BioRasi. She brings knowledge of both hands-on lab bench experience in research and development, managing laboratory operations, and supervising project management and lab staff. Currently Lindsay is helping develop the LA bioscience ecosystem, as Director of BioLabs LA at the Lundquist Institute and co-chair of the Biocom California LA Startup Resources Committee.
iCONM in collaboration with BioLabsについて
iCONM in collaboration with BioLabsは、羽田空港の対岸に位置する川崎市殿町キングスカイフロントにある「ナノ医療イノベーションセンター（iCONM）」内にある、ライフサイエンス分野のスタートアップを支援するインキュベーション施設です。日本の高い研究技術力に 対して、iCONMの研究支援環境と米国ボストンにあるバイオ領域のグローバルインキュベーター BioLabsの社会実装支援経験の強みをかけ合わせ、スタートアップを支援します。iCONM in collaboration with BioLabsでは、 370種類を超える、微細加工・化学合成・バイオ・動物実験系の共用機器を備えています。【入居者募集中・入居にご関心が有る方へ】
iCONM in collaboration with BioLabs